Table 2. Results of Cox regression analysis of the hazard ratios stratified patients’ gender and age, tumour stage and mutational status.
Variable | Category | P-value | HR | 95% CI for HR | |
---|---|---|---|---|---|
Lower | Upper | ||||
Gender | Male | 0.081 | 1.77 | 0.93 | 3.36 |
Female* | 1.00 | ||||
Age | = < 50 | 0.042 | 0.41 | 0.18 | 0.97 |
51–60 | 0.002 | 0.26 | 0.11 | 0.61 | |
61–70 | 0.091 | 0.54 | 0.26 | 1.10 | |
= 71+ * | 1.00 | ||||
Stage T | T2 | 0.851 | 1.09 | 0.44 | 2.70 |
T3 | 0.238 | 0.68 | 0.35 | 1.30 | |
T4* | 1.00 | ||||
Stage N | N0 | 0.839 | 0.91 | 0.369 | 2.248 |
N1 | 0.417 | 0.737 | 0.352 | 1.541 | |
N2* | 1.00 | ||||
Stage M | M0 | 0.256 | 0.61 | 0.26 | 1.44 |
M1 | 0 | 3.81 | 1.83 | 7.93 | |
Mx* | 1.00 | ||||
Mutation | Wild | 0.099 | 1.68 | 0.91 | 3.11 |
KRAS* | 1.00 |